通过使用抗炎可生物降解药物补丁增强术后心房的预防能力
Pengcheng Yu1,2, Weiqi Lu3, Huaxin Sun4
1Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Regenerative biomaterials
|June 27, 2025
概括
一种新型的安德罗格拉化物加载的聚合物贴片通过减少炎症和氧化应激,有效地预防手术后心房动 (POAF). 这种有针对性的输送系统为心律失常和相关心血管疾病提供了一个有希望的新疗法.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后心房动 (POAF) 是一种常见的并发症,增加了心血管风险.
- 目前对POAF的治疗有局限性,需要新的治疗策略.
研究的目的:
- 为预防POAF开发和评估一种含有andrographolide (Andr) 的可降解聚合物补丁.
- 在临床前模型中研究安德尔贴片的抗炎和抗氧化机制.
主要方法:
- 一个向的andrographolide-loaded聚合物贴片的设计,用于心房输送.
- 使用无菌心膜炎 (SP) 鼠标模型来模拟POAF.
- 采用电生理学检测,免疫光,西斑,PCR和基于细胞的测试 (HL-1细胞) 来评估疗效和机制.
主要成果:
- 安德尔贴片在SP大鼠模型中显著减少了POAF发病率,从90%降至20%.
- 已证明减少心房炎症,氧化应激,细胞死亡和反应性氧物种 (ROS) 生成.
- 显示抑制M1巨细胞极化和细胞内 (Ca2+) 和ROS平衡的调节.
结论:
- 在临床前模型中,安德罗格拉福利德载入的心房贴片有效预防POAF.
- 治疗效果归因于调节炎症微环境,ROS平衡和Ca2+平衡.
- 该策略为治疗心律失常疾病和其他与ROS和Ca2+失调相关的局部疾病提供了一种新方法.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
653
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
653
01:23Peripheral Artery Disease V: Postoperative Nursing Management
28
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
28
01:27Peripheral Artery Disease III: Interprofessional Care
33
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
33
01:29Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921